{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:45:44Z","timestamp":1789706744343,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.jacl.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T09:59:35Z","timestamp":1265104775000},"page":"99-104","source":"Crossref","is-referenced-by-count":15,"title":["Non-HDL-cholesterol\/apolipoprotein B ratio: A useful distinguishing feature in the screening for type III hyperlipoproteinemia"],"prefix":"10.1016","volume":"4","author":[{"given":"Toshio","family":"Murase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2010.01.004_bib1","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"2835","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2001"},{"key":"10.1016\/j.jacl.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7326\/0003-4819-82-2-150","article-title":"Type III hyperlipoproteinemia: analysis of two contemporary deficiencies","volume":"82","author":"Fredrickson","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2010.01.004_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1373\/clinchem.2004.047001","article-title":"Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations","volume":"51","author":"Blom","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacl.2007.07.006","article-title":"Diagnosis of type III hyperlipoproteinemia from total cholesterol, triglyceride, and apolipoprotein B","volume":"1","author":"Sniderman","year":"2007","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2010.01.004_bib5","first-page":"743","article-title":"Apolipoprotein E to B ratio: a marker for type III hyperlipoproteinemia","volume":"31","author":"M\u00e4rz","year":"1993","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.jacl.2010.01.004_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cccn.2004.04.018","article-title":"Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2\/2 phenotype","volume":"348","author":"Toda","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1530\/acta.0.1100456","article-title":"Hyperlipidaemia in patients with hypopituitarism","volume":"110","author":"Ishibashi","year":"1985","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.jacl.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0026-0495(83)90220-2","article-title":"Accumulation of intermediate density lipoprotein in the plasma of cholesterol-fed hypothyroid rats","volume":"32","author":"Murase","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2010.01.004_bib9","first-page":"187","article-title":"A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis","volume":"140","author":"Okubo","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2010.01.004_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-8981(00)00328-4","article-title":"Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency","volume":"301","author":"Arai","year":"2000","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-1019000","article-title":"Plasma apolipoprotein E levels in hypertriglyceridemia","volume":"14","author":"Yamada","year":"1982","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jacl.2010.01.004_bib12","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI115507","article-title":"Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency","volume":"88","author":"Gotoda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2010.01.004_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9150(96)06061-3","article-title":"A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene deficiency and apoE4 in a severely hypertriglyceridemic patient","volume":"130","author":"Okubo","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/clinchem\/47.9.1579","article-title":"Evaluation of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays","volume":"47","author":"Warnick","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MPA.0b013e3181771659","article-title":"Pancreatitis caused by hypertriglyceridemia in a patient compound heterozygous for Leu334Phe and \u2014514C\u2192T in the hepatic lipase gene","volume":"38","author":"Ebara","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.jacl.2010.01.004_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2009.03.046","article-title":"A novel APOA5 splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient","volume":"207","author":"Okubo","year":"2009","journal-title":"Atherosclerosis"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287410000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T07:18:21Z","timestamp":1590563901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287410000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1933287410000437"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2010.01.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}